Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000986248 | SCV001135184 | uncertain significance | Charcot-Marie-Tooth disease type 2A2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001232650 | SCV001405215 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2024-11-11 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the MFN2 gene (p.Gln754Alafs*9). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 4 amino acid(s) of the MFN2 protein and extend the protein by 4 additional amino acid residues. This variant is present in population databases (rs773371488, gnomAD 0.02%). This frameshift has been observed in individuals with Charcot-Marie-Tooth disease and/or optical atrophy (PMID: 16762064, 28215760, 33841295, 34354735). This variant is also known as c.2257_2258insT and c.2258_2259insT (L753fs). ClinVar contains an entry for this variant (Variation ID: 637433). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Istituto Neurologico Mediterraneo, |
RCV000986248 | SCV001424047 | pathogenic | Charcot-Marie-Tooth disease type 2A2 | 2020-01-26 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003147548 | SCV003836398 | likely pathogenic | Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; | 2022-03-17 | criteria provided, single submitter | clinical testing | |
Inherited Neuropathy Consortium | RCV000789613 | SCV000928978 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Clinical Genetics, |
RCV001700461 | SCV001926028 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700461 | SCV001966848 | pathogenic | not provided | no assertion criteria provided | clinical testing |